Sonu S Ahirwar

Sonu S Ahirwar

Vishesh Jupiter Hospital, Indore, Madhya Pradesh, India

Profile ID RP-000-2456 Joined 2023-01-18 2 articles
1
Total Views
2
Total Publications
1
Publication Views

Articles(2)

Authors: Sonu S Ahirwar*

DOI: 10.18231/j.ijmr.2021.045  

Volume8

Issue3

Pages219-223

Abstract

Purpose: Mucormycosis (MC) is a serious threat in this covid-19 pandemic situation; cases of MC continue to increases as post covid-19 disease affliction in India. It is a life-threatening disease that happens due to black mold. Mucormycosis is described as a potentially lethal infection amongst immune-compromised (IC) hosts, particularly in those with diabetes, leukemia, and lymphoma. Mortality rate of MC just doubles in IC host, delayed diagnosis increase the rate of mortality. Mucormycosis is difficult to diagnose which affects outcomes and results in a poor prognosis. The main objective of the study was to detect MC in the clinical species received during or post covid-19 treatment in our laboratory. Materials and Methods: Basic microbiological methods such as gram stain and KOH smear were used for the detection of MC in the received clinical specimen and morphology was seen in the microscope. Results: The is a cross-sectional observational study conducted in our microbiology laboratory for one month periods during May 15, 2021 to June 15, 2021 in a tertiary care hospital of central India. During study period our microbiology lab received n=35 suspected clinical specimens from N= 27 post covid-19 patients for MC diagnosis over one month period. Out of n=35 specimens, n=8 specimens (obtained from N=5 patients) were positive for MC by gram and KOH smear method and we saw filamentous fungi by conventional microscopic method. Conclusions: The present study concluded that the cases of life threatening MC increase day by day in central India as post complication of covid-19 disease.   Keywords: Mucormycosis, Immuno­compromised, Diagnosis, Covid- 19.

View Article

Authors: Sonu S. Ahirwar, Prabhat Jatav, Kirti Kushwaha

DOI: 10.18231/j.ijmmtd.2021.022  

Volume7

Issue2

Pages100-102

Abstract

Methicillin-resistant coagulase-negative staphylococci (MR-CoNS) associated infection is a growing concern in healthcare settings now a day. MR-CoNS are the main infectious agents of the hospital acquired infection. Clinical staffs to patients transmission of resistant strains have caused a rapid increase in the prevalence of antimicrobial resistance in recent years. Growing rate of antimicrobial resistant against available antibiotics of MR-CoNS is a developing problem in low income or lower middle income counties. Aim: This study was conducted to determine the occurrence MR-CoNS isolated from different clinical staffs of tertiary care hospital. Materials and Methods: This prospective study conducted in clinical staffs, nasal swab were collected from all the participants. Screening of CoNS were done on the basis of cultural, morphological and biochemical tests, identification and AST analysis done by VITEK-2 automated system. Methicillin resistance pattern was checked by VITEK-2 and Kirby-Bauer disc diffusion method according to CLSI guideline. Results: A total of 129 nasal swab samples were collected from clinical staffs, of which n=81 isolates (85.6%) were CoNS. Among n=81 CoNS, (48.12%) S. epidermidis, (41.97%) S. haemolyticus, (7.4%) S. lugdunensis and S. saprophyticus (2.4%) were reported. Out of n=81 CoNS isolates, n=26 were conformed as MR-CoNS. Maximum methicillin resistance were reported in S. epidermidis 53.48% (14/26), S. haemolyticus 42.30% (11/26), S. lugdunensis 3.84% (1/26) and S. saprophyticus 0% (0/26). Conclusion: The occurrence rate of MR-CoNS are higher (20.6%) in the healthcare workers and most of the methicillin resistant-CoNS isolates shows high level of resistance against widely used antibiotics but all the isolates susceptible against vancomycin. Keywords: MR-CoNS, CoNS, Hospital Associated Infection, Clinical staffs, Oxacillin-Cefoxitin screening.

View Article

No matching articles

Try another word from the title, author or DOI.